Latest in Research

  • JDRF Research Strategy: Cures and Improving Lives

    May 31, 2019

    They shared new developments and applauded the speed of scientific advancements. At this year’s Strategic Research Session, the tone was dynamic as...

  • The 20th Anniversary of the Edmonton Protocol

    March 11, 2019

    This day, 20 years ago, a person with type 1 diabetes (T1D) was cured. Well, pseudo-cured. On March 11, 1999, the Edmonton...

  • Strengthening Type 1 Diabetes Science by Building Careers

    March 24, 2020

    Sometimes, the funding that JDRF can provide for researchers is exactly the invitation they need to get into the field of type...

  • Saving Vision, Changing Lives

    March 12, 2020

    Dr. Sun thinks the next phase of research is to combine that kind of personal imaging data with electronic medical data that...

  • A Scientist Sees Kidney Disease Through New Eyes

    March 10, 2020

    Funding kidney complications research is extremely important to JDRF. Please consider donating today, as we help those with T1D today and work to...

  • Mission Summit Salutes the Power of Us in Both Driving to Cures and Supporting the T1D Community

    February 6, 2020

    Ellen Leake, Chair of the International Board of Directors

  • Top 10 T1D Breakthroughs of the Year

    December 20, 2019

    There’s 11 days left in 2019, but what did JDRF see this year that said “breakthrough”? This top 10 list reflects advances...

  • One Scientist, One Goal: To End Diabetic Eye Disease, Forever

    December 17, 2019

    It’s a devastating statistic: More than 90% of people with type 1 diabetes (T1D) develop diabetic eye disease within 20 years of...

  • Two Scientists, Finding Ways to Prevent Diabetic Kidney Disease

    December 10, 2019

    It’s a devastating statistic: 1 in 4 people with type 1 diabetes (T1D) are affected by kidney disease. But thanks to Monika...

  • The Promising Clinical Trials in the JDRF Pipeline

    December 9, 2019

    As the leading global funder of type 1 diabetes (T1D) research, JDRF invests in the most promising research studies across the world—including...